Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research
EBITDA rose to Rs. 218.1 crore, a 14.8% year-on-year increase
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
The submission is supported by results from the Phase 3b APEX study
NewCo’s pipeline includes five investigational medicines
For patients with resectable early-stage gastric and gastroesophageal junction cancers
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
Subscribe To Our Newsletter & Stay Updated
